News

BLUEMOTH Introduces First-of-its-Kind Digital Prescription Hearing Technology Experience

The company offers a new destination for consumers to discover, try-on and purchase personalized hearing technology with audiologist supportSEATTLE, Aug.…

1 year ago

Syneos Health Stockholders Approve Agreement with Private Investment Consortium

MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading…

1 year ago

Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market

-Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application of broadleaf weed control as…

1 year ago

Petalfast Joins Forces with MATU to Bring Premium All-In-One Surf Vapes to the Massachusetts Cannabis Market

IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with…

1 year ago

Physician Partner of Castle Connolly Private Health Partners, Gary D. Schwartz, MD, Appointed to Valley Hospital

Gary D. Schwartz, MD Schwartz CCPHPPARAMUS, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Gary D. Schwartz, M.D., a board-certified internist…

1 year ago

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing…

1 year ago

RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update

-- Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET --BRIDGEWATER, N.J., Aug. 02, 2023 (GLOBE…

1 year ago

Aridis Pharmaceuticals Announces $2 Million Offering

Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS), a biopharmaceutical company focused on the…

1 year ago

X4 Pharmaceuticals to Report Second-Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 10, 2023

BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel…

1 year ago

Candel Therapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference

NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage…

1 year ago